Alma Lasers, a Buffalo Grove, IL affiliate of an Israeli company with the same name, is reporting that its fractional ablative device, the Pixel® CO2 OMNIFIT, has been cleared by the FDA for marketing in the United States.
The following is from the press release:
The Pixel CO2 OMNIFIT is Alma’s newest offering in skin rejuvenation and it is an upgrade to physicians’ existing CO2 skin resurfacing lasers. It is designed to provide patients with impressive results with just a fraction of the downtime compared to current treatments, and for significantly less money than replacing their current laser.
The Pixel CO2 OMNIFIT handpiece fits onto most existing CO2 lasers and is designed to deliver a high degree of efficacy without the side effects or significant downtime associated with traditional CO2 resurfacing. By combining Alma’s proprietary and proven Pixel fractional technology with a standard CO2 resurfacing laser, the new Pixel CO2 OMNIFIT delivers a supremely effective treatment for aged, photo-damaged, and acne-scarred skin with minimal patient redness, irritation or downtime…
The Pixel CO2 OMNIFIT handpiece takes ablative patient downtime from 30 days to approximately three, making the procedure as appealing as many non-invasive approaches available to today’s busy patients.